+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI in Cancer Diagnostics Market - Global Forecast 2026-2032- Product Image
AI in Cancer Diagnostics Market - Global Forecast 2026-2032- Product Image
New

AI in Cancer Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5716125
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AI in cancer diagnostics is reshaping the oncology landscape as advanced algorithms and integrated platforms drive clinical adoption worldwide. Senior healthcare leaders face critical choices about integrating new AI solutions to improve accuracy, efficiency, and care delivery while managing evolving risks and regulations.

Market Snapshot: AI in Cancer Diagnostics Market

The AI in Cancer Diagnostics Market grew from USD 326.78 million in 2025 to USD 391.86 million in 2026. It is expected to continue growing at a CAGR of 22.16%, reaching USD 1.32 billion by 2032. This trajectory reflects rapid upscaling from pilot projects to clinical workflows. Growth is driven by enhanced computational capabilities, maturing machine learning algorithms, and the expanding availability of structured and unstructured healthcare data. Adoption is accelerating in imaging, genomics, and pathology domains as hospitals and laboratories pursue operational readiness and improved outcomes.

Scope & Segmentation

  • Application Segments: Encompasses diagnostic imaging (CT, MRI, PET, ultrasound), genomic profiling (DNA, RNA, epigenetics), digital pathology, predictive analytics (outcome prediction, risk stratification), and treatment planning (radiotherapy, surgical guidance).
  • Component Segments: Hardware for imaging and sample processing, software for analytics and workflow orchestration (on-premise and cloud-based), and services including professional and managed offerings.
  • End-Users: Diagnostic laboratories, hospitals and clinics, pharmaceutical companies, and research institutes, each with unique integration and compliance requirements.
  • Cancer-Type Specialization: Tailored approaches for breast, colorectal, lung, prostate, and other cancers, necessitating adaptation to different imaging protocols and biomarker prevalence.
  • Technology Types: Includes deep learning, traditional machine learning, and natural language processing, influencing validation frameworks and computational requirements.
  • Regional Coverage: Americas (emphasis on operational integration and payer dynamics), Europe, the Middle East & Africa (diverse regulatory needs and data compliance), and Asia-Pacific (centralized programs, rapid scale-up, infrastructure diversity).

Key Takeaways

  • AI-driven solutions are becoming routine in clinical environments, automating repetitive diagnostics and supporting complex interpretation tasks to enhance clinician performance and confidence.
  • Effective deployment depends on regulatory planning, robust clinical validation, and seamless electronic health record integration, shifting these factors from optional features to baseline requirements for adoption.
  • Ecosystem maturity has created tightly linked value chains involving cloud providers, semiconductor manufacturers, and specialized vendors, supporting both scalability and data management.
  • Payors and procurement teams are assessing value based on operational impact, such as improved throughput and clinical efficiency, alongside accuracy enhancements.
  • Stakeholders prioritizing organizational readiness, ongoing staff training, and structured monitoring frameworks will accelerate meaningful AI adoption and realize more reliable diagnostic outcomes.

Tariff Impact on Supply Chains

The cumulative effect of US and global tariff policies since 2025 has injected complexity into supply chains supporting AI-enabled cancer diagnostics. Increased import duties on imaging equipment, specialty components, and laboratory reagents have raised capital equipment costs and prompted procurement teams to pursue localization and diversified sourcing.

  • Manufacturers are revisiting their launch strategies and may delay deployments or focus on low-tariff regions, influencing the speed of technology diffusion.
  • Cross-border compliance costs and customs requirements are leading to longer procurement cycles and higher administrative burdens for hospitals and laboratories.
  • Interest in modular and software-centric solutions has risen, as these offerings can mitigate tariff-related risk by leveraging local hardware or cloud platforms.

Organizations increasingly favor diagnostic tools with measurable downstream efficiency improvements or operational cost reductions when confronted with tariff-driven price pressures.

Methodology & Data Sources

This report is underpinned by a hybrid methodology integrating systematic secondary literature review, structured stakeholder interviews, and cross-validated thematic analysis. Analytical sources included clinical studies, regulatory guidance, technology white papers, and industry disclosures.

Why This Report Matters

  • Enables decision-makers to benchmark commercial models, regulatory strategies, and clinical integration practices across global markets.
  • Provides actionable segmentation to guide product development, procurement, and partnership investment for differentiated clinical value.
  • Delivers rigorous, triangulated intelligence that addresses evolving risks in supply chain, regulation, and real-world performance monitoring.

Conclusion

AI in cancer diagnostics is driving measurable shifts in clinical practice and operational strategy. Leaders who align clinical validation, modular deployment, and payer engagement will convert innovation into lasting adoption and improved patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. AI in Cancer Diagnostics Market, by Application
8.1. Diagnostic Imaging
8.1.1. CT Imaging
8.1.2. MRI Imaging
8.1.3. PET Imaging
8.1.4. Ultrasound Imaging
8.2. Genomic Profiling
8.2.1. DNA Sequencing
8.2.2. Epigenetic Analysis
8.2.3. RNA Sequencing
8.3. Pathology
8.3.1. Digital Pathology
8.3.2. Histopathology
8.4. Predictive Analytics
8.4.1. Outcome Prediction
8.4.2. Risk Assessment
8.5. Treatment Planning
8.5.1. Radiotherapy Planning
8.5.2. Surgical Planning
9. AI in Cancer Diagnostics Market, by Component
9.1. Hardware
9.2. Services
9.2.1. Managed Services
9.2.2. Professional Services
9.3. Software
9.3.1. Cloud Based
9.3.2. On Premises
10. AI in Cancer Diagnostics Market, by End User
10.1. Diagnostic Laboratories
10.2. Hospitals And Clinics
10.3. Pharmaceutical Companies
10.4. Research Institutes
11. AI in Cancer Diagnostics Market, by Cancer Type
11.1. Breast Cancer
11.2. Colorectal Cancer
11.3. Lung Cancer
11.4. Prostate Cancer
12. AI in Cancer Diagnostics Market, by Technology
12.1. Deep Learning
12.2. Machine Learning
12.3. Natural Language Processing
13. AI in Cancer Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. AI in Cancer Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. AI in Cancer Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States AI in Cancer Diagnostics Market
17. China AI in Cancer Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories Inc
18.6. Aidoc Medical
18.7. Aiforia Technologies
18.8. Azra AI
18.9. C the Signs
18.10. ConcertAI LLC
18.11. Enlitic Inc
18.12. F. Hoffmann-La Roche Ltd
18.13. Flatiron Health Inc
18.14. Foresight Diagnostics
18.15. GE HealthCare
18.16. GRAIL Inc
18.17. Ibex Medical Analytics
18.18. IBM Corporation
18.19. Intuitive Surgical Inc
18.20. Kheiron Medical Technologies Limited
18.21. Koninklijke Philips N.V.
18.22. Lunit Inc
18.23. Medial EarlySign
18.24. Medtronic Plc
18.25. Microsoft Corporation
18.26. NVIDIA Corporation
18.27. Paige AI Inc
18.28. PathAI Inc
18.29. Qure.ai Technologies Private Limited
18.30. Siemens Healthineers AG
18.31. SkinVision
18.32. Tempus AI Inc
18.33. Viz.ai Inc
18.34. Zebra Medical Vision
List of Figures
FIGURE 1. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CT IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CT IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CT IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MRI IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MRI IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MRI IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PET IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PET IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY OUTCOME PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY OUTCOME PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RADIOTHERAPY PLANNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RADIOTHERAPY PLANNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RADIOTHERAPY PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL PLANNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL PLANNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON PREMISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 178. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 179. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 180. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 182. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 183. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 204. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 205. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 206. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 207. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 208. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 209. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 210. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 211. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 213. AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 228. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 231. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 232. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 233. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 234. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 235. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 236. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 237. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 238. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 240. ASEAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 244. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 245. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 246. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 247. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 248. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 249. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 250. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 251. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 253. GCC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 267. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 270. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 271. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 272. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 273. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 274. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 275. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 276. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 277. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 279. BRICS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 280. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 281. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 282. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 283. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 284. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 285. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 286. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 287. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 288. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 289. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 290. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 292. G7 AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 293. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 295. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 296. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 297. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 298. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 299. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 300. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 301. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 302. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 303. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 305. NATO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 306. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 315. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 317. UNITED STATES AI IN CANC

Companies Mentioned

The key companies profiled in this AI in Cancer Diagnostics market report include:
  • Abbott Laboratories Inc
  • Aidoc Medical
  • Aiforia Technologies
  • Azra AI
  • C the Signs
  • ConcertAI LLC
  • Enlitic Inc
  • F. Hoffmann-La Roche Ltd
  • Flatiron Health Inc
  • Foresight Diagnostics
  • GE HealthCare
  • GRAIL Inc
  • Ibex Medical Analytics
  • IBM Corporation
  • Intuitive Surgical Inc
  • Kheiron Medical Technologies Limited
  • Koninklijke Philips N.V.
  • Lunit Inc
  • Medial EarlySign
  • Medtronic Plc
  • Microsoft Corporation
  • NVIDIA Corporation
  • Paige AI Inc
  • PathAI Inc
  • Qure.ai Technologies Private Limited
  • Siemens Healthineers AG
  • SkinVision
  • Tempus AI Inc
  • Viz.ai Inc
  • Zebra Medical Vision

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 391.86 Million
Forecasted Market Value ( USD ) by 2032 $ 1320 Million
Compound Annual Growth Rate22.1%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Next-Generation Breast Cancer Diagnostic & Screening Market - Global Forecast 2026-2032 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Head & Neck Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Head & Neck Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Artificial Intelligence in Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Artificial Intelligence in Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts - Product Image

Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts

  • Report
  • 200 Pages
  • Global
From
AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.